Trading Halt Active
This ticker is currently halted. Check the Halts tab for details.
Volatility Alert
This ticker is experiencing unusual price movement.
Key Stats
Day Range
$11.71
$12.63
52-Week Range
$9.46
$23.29
14-Day RSI
-
Upcoming Earnings
---
---
Volume
-
Analyst Rating
-
-
-
-
Price Target
-
-
Last Earnings
-
-
About
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Valuation
1.00B
Market Cap
-
Forward P/E
-
Trailing P/E
-
Price/Book
-
EPS (TTM)
Financial Snapshot
-
Revenue (TTM)
-
EBITDA
-
Free CF
-
Total Debt
-
Beta
Margins & Dividends
-
Gross Margin
-
Op. Margin
-
Div Rate
-
Div Yield
-
Ex-Div Date
Profile
-
Sector
-
Industry
-
Short % Float
Nearest Expiry:
Loading...
Max Pain:
$0.00
Support (Put Wall)
$0.00
OI: 0
Current Price
$0.00
Resistance (Call Wall)
$0.00
OI: 0
Calls
Loading...
Puts
Loading...
Unusual Whale Flow
Loading anomaly scanner...
Experimental. Executive-branch trades are sourced from a third-party aggregator (open-cabinet.org) that parses OGE filings — not yet independently verified. Most executive-branch filings are bonds; only trades resolved to an equity ticker appear here.